|
|
| (2 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Benazepril#Clinical Studies]] |
| {{Benazepril}}
| |
| {{CMG}} ; {{AE}} {{AM}}
| |
| | |
| ==Clinical Studies==
| |
| | |
| ====Hypertension====
| |
| | |
| ======Adult======
| |
| | |
| In single-dose studies, Lotensin lowered [[blood pressure]] within 1 hour, with peak reductions achieved 2-4 hours after dosing. The [[antihypertensive]] effect of a single dose persisted for 24 hours. In multiple-dose studies, once-daily doses of 20-80 mg decreased seated pressure (systolic/diastolic) 24 hours after dosing by about 6-12/4-7 mmHg. The trough values represent reductions of about 50% of that seen at peak.
| |
| | |
| Four dose-response studies using once-daily dosing were conducted in 470 mild-to-moderate [[hypertensive]] patients not using diuretics. The minimal effective once-daily dose of Lotensin was 10 mg; but further falls in [[blood pressure]], especially at morning trough, were seen with higher doses in the studied dosing range (10-80 mg). In studies comparing the same daily dose of Lotensin given as a single morning dose or as a twice-daily dose, blood pressure reductions at the time of morning trough blood levels were greater with the divided regimen.
| |
| | |
| The [[antihypertensive]] effects of Lotensin were not appreciably different in patients receiving high- or low-sodium diets.
| |
| | |
| In normal human volunteers, single doses of benazepril caused an increase in [[renal blood flow]] but had no effect on [[glomerular filtration rate]].
| |
| | |
| Use of Lotensin in combination with [[thiazide diuretics]] gives a blood-pressure-lowering effect greater than that seen with either agent alone. By blocking the renin-angiotensin-aldosterone axis, administration of Lotensin tends to reduce the [[potassium]] loss associated with the diuretic.
| |
| | |
| ======Pediatric======
| |
| | |
| In a clinical study of 107 pediatric patients, 7 to 16 years of age, with either [[systolic]] or [[diastolic pressure]] above the 95th percentile, patients were given 0.1 or 0.2 mg/kg then titrated up to 0.3 or 0.6 mg/kg with a maximum dose of 40 mg once daily. After four weeks of treatment, the 85 patients whose blood pressure was reduced on therapy were then randomized to either placebo or benazepril and were followed up for an additional two weeks. At the end of two weeks, [[blood pressure]] (both systolic and diastolic) in children withdrawn to placebo rose by 4 to 6 mmHg more than in children on benazepril. No dose-response was observed for the three doses.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOTENSIN (BENAZEPRIL HYDROCHLORIDE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d954024-a191-46e3-ba71-2a7d5b0c65d5#nlm34067-9 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |